800 Victorians sought for COVID-19 booster shot trial
09 May, 2022The CEPI and the MCRI are inviting participation for a global trial investigating whether vaccinating people with a lower COVID-19 booster dose is just as effective as a full dose, but with fewer side effects.
Good IPC programs can reduce infections by 70% — WHO
09 May, 2022Recent disease outbreaks have highlighted how healthcare settings can contribute to the spread of infections, if insufficient attention is paid to infection prevention and control.
Study explores AMR bacteria presence in supermarket meat
09 May, 2022New report claims there is an alarming proportion of antimicrobial resistant bacteria in packaged beef and salmon from Australian supermarkets.
Hepatitis cases of unknown origin raise concerns
02 May, 2022More than 11 countries around the world, including the US, UK, Spain, Israel, Denmark, Norway and France among other countries, have reported acute, severe hepatitis of unknown origin.
Australian innovation delivering standardised frontline ultrasound infection prevention
01 May, 2022In Australia, patients will suffer from an estimated 165,000 healthcare-associated infections (HAIs) each year.
New coating for implants, medical devices cuts infection risk
29 April, 2022Infections after hip replacements and from orthopaedic device procedures can be complicated and lead to painful and repeat surgeries.
Drug-resistant environmental mould causes lung infections
27 April, 2022Drug-resistant mould is spreading from the environment and infecting susceptible people's lungs, reveals a new study led by Imperial College London.
Proposal for assessing long COVID patients
26 April, 2022A new assessment proposal aimed at clinicians and researchers hopes to help to establish an individualised treatment protocol for long COVID patients.
Delta variant's invasion trick to evade immune response
21 April, 2022COVID-19's Delta variant may use a novel invasion method to evade the body's immune response, causing damage to the brain, intestine and kidneys, a Griffith University study has found.
Meningitis vaccines could help tackle untreatable gonorrhoea
13 April, 2022Latest studies from South Australia and the US have indicated that meningitis vaccines could help improve protection against gonorrhoea.
UTIs are becoming more deadly, thanks to AMR — CSIRO
06 April, 2022The spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs) — which affect around one in two women and one in 20 men in their lifetime.
How can air purifiers help aged care facilities protect residents and staff from harmful viruses?
28 March, 2022 by Kate Smith, Head of Clinical Solutions, Training and Support – GAMA Healthcare (RN/RM, GCertNurs, Cert IV TAE)As winter approaches, with its associated colds and flu, many aged care and long term care facilities will be looking for additional methods to protect their residents and staff.
COVID-19 taskforce publishes new risk classification tool
21 March, 2022The National COVID-19 Clinical Evidence Taskforce (NCCET) has developed a risk classification tool to guide clinicians making decisions about which people are most likely to benefit from drugs.
How antimicrobial resistance spreads inside the human gut
21 March, 2022A collaboration between the Hudson Institute of Medical Research and the Wellcome Sanger Institute, Cambridge UK, explores how antimicrobial resistance (AMR) spreads inside the human gut.
Shingrix approved for Australians 18+ at high risk
14 March, 2022GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.
